Hachenberg J
No ORCID on file
· 3 papers in corpus
· active 2021-2026
Mirvetuximab-soravtansine (MIRV-S) is an antibody-drug conjugate targeting folate receptor alpha (FOLR1). MIRV-S is approved for the treatment of FOLR1-positive, platinum-resistant ovarian carcinoma. Patient eligibility is determined by imm…
Objectives: Chronic pelvic pain (CPP) is defined as intermittent or constant pain in the lower abdomen or pelvis for a duration of 6 months that is not exclusively associated with menstruation or sexual intercourse. Laparoscopic ablation of…
BackgroundThe implementation of assisted reproductive techniques (ART) is a complex treatment requiring both a good cooperation between various professional groups in the fertility centre, and the patient's and her partner's cooperation. Ac…